Medicilon Preclinical Nociceptive Pain Models
Currently, Medicilon possess different types of pain including acute pain, inflammatory pain, and neuropathic pain.
16 4 月, 2024
Blog
Medicilon Preclinical Inflammatory & Immune Diseases Models
Medicilon provides a number of validated models of inflammatory and autoimmune diseases.
16 4 月, 2024
Medicilon Ophthalmic Animal Models
Dry eye, also known as dry eye disease (DED), dry eye syndrome, and keratoconjunctivitis sicca (KCS), is a multifactorial disease of the ocular surface.
16 4 月, 2024
FAQ – Key Points On Preclinical Research On Inhaled Preparations
Preclinical research for inhaled formulations is the stage in which inhaled formulations are comprehensively evaluated and validated prior to clinical trials.
11 3 月, 2024
Let’s see how Medicilon helps innovative pharmaceutical companies go overseas?
Let’s see how Medicilon helps innovative pharmaceutical companies go overseas?
21 2 月, 2024
FAQ – About the role of in vitro bioequivalence testing in the development of new drugs
Bioequivalence (BE) testing is of great significance to the development of new drugs.
21 2 月, 2024
FAQ-Strategies to avoid oil precipitation during crystallization of small molecule compounds
Medicilon has consolidated the frequently asked questions during the live broadcast for everyone, hoping to further help and reduce the worries about oil precipitation/crystallization.
21 2 月, 2024
Application and Case Studies Sharing of bDNA Technology for Oligonucleotide and mRNA Drug Bioanalysis
bDNA technology is branch DNA technology, which is one analytical technology integrating molecule labeling, probe design, molecule hybridization, fluorescence or chemiluminescence detection.
5 1 月, 2024
World Immunization Day – Since the immunity track has become popular, Medicilon will help you seize the 100 billion blue ocean market!
Autoimmune diseases have long occupied the second largest disease market after cancer globally.
25 12 月, 2023
[World Alzheimer’s Day] After a hundred years of fighting, how far are we from ending Alzheimer’s disease?
September 21, 2023 is the 30th World Alzheimer’s Day. Alzheimer’s disease (AD) is a neurodegenerative disease common in the elderly. The main pathological changes are diffuse atrophy of the cerebral cortex, intraneuronal fibrillary tangles, and the formation of a large number of senile plaques between nerve cells. Progressive cognitive impairment and memory loss are its main clinical symptoms.
7 10 月, 2023
You might be interested in:
